WA
QLTY icon

Win Advisors’s GMO US Quality ETF QLTY Stock Holding History

Win Advisors’s Portfolio QLTY Stock Details QLTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,532
Closed -$453K – 106
2026
Q1 		$453K Buy
+12,532
New +$481K 0.21% 63

Other funds holding QLTY

AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
TODC
Trustees of Dartmouth College Hanover, New Hampshire $335M AUM 18.36% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $1.07B AUM 26.49% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Win Advisors's QLTY Position: Q2 2026 in Review

Win Advisors sold out of GMO US Quality ETF (QLTY) in Q2 2026, closing a stake of 12,532 shares — an estimated $453K sold.

Win Advisors first reported a position in QLTY in Q1 2026 and held it in 1 quarter. The position peaked at $453K in Q1 2026. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Win Advisors reported no remaining GMO US Quality ETF position as of Q2 2026 after selling out during the quarter.
  • Win Advisors sold 12,532 GMO US Quality ETF shares in Q2 2026, an estimated $453K.
  • Win Advisors first reported a position in GMO US Quality ETF in Q1 2026 and held it in 1 quarter.
  • Win Advisors's GMO US Quality ETF position peaked at $453K in Q1 2026.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Win Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.